ArticleCancers2019

Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients.

Emma Boydell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.